FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4327575214> ?p ?o ?g. }

• W4327575214 endingPage "404" @default.
• W4327575214 startingPage "404" @default.
• W4327575214 abstract "Importance Persistent tinnitus is common, disabling, and difficult to treat. Objective To evaluate the association between circulating metabolites and persistent tinnitus. Design, Setting, and Participants This was a population-based case-control study of 6477 women who were participants in the Nurses’ Health Study (NHS) and NHS II with metabolomic profiles and tinnitus data. Information on tinnitus onset and frequency was collected on biennial questionnaires (2009-2017). For cases, metabolomic profiles were measured (2015-2021) in blood samples collected after the date of the participant’s first report of persistent tinnitus (NHS, 1989-1999 and 2010-2012; NHS II, 1996-1999). Data analyses were performed from January 24, 2022, to January 14, 2023. Exposures In total, 466 plasma metabolites from 488 cases of persistent tinnitus and 5989 controls were profiled using 3 complementary liquid chromatography tandem mass spectrometry approaches. Main Outcomes and Measures Logistic regression was used to estimate odds ratios (ORs) of persistent tinnitus (per 1 SD increase in metabolite values) and 95% CIs for each individual metabolite. Metabolite set enrichment analysis was used to identify metabolite classes enriched for associations with tinnitus. Results Of the 6477 study participants (mean [SD] age, 52 [9] years; 6477 [100%] female; 6121 [95%] White individuals) who were registered nurses, 488 reported experiencing daily persistent (≥5 minutes) tinnitus. Compared with participants with no tinnitus (5989 controls), those with persistent tinnitus were slightly older (53.0 vs 51.8 years) and more likely to be postmenopausal, using oral postmenopausal hormone therapy, and have type 2 diabetes, hypertension, and/or hearing loss at baseline. Compared with controls, homocitrulline (OR, 1.32; (95% CI, 1.16-1.50); C38:6 phosphatidylethanolamine (PE; OR, 1.24; 95% CIs, 1.12-1.38), C52:6 triglyceride (TAG; OR, 1.22; 95% CIs, 1.10-1.36), C36:4 PE (OR, 1.22; 95% CIs, 1.10-1.35), C40:6 PE (OR, 1.22; 95% CIs, 1.09-1.35), and C56:7 TAG (OR, 1.21; 95% CIs, 1.09-1.34) were positively associated, whereas α-keto-β-methylvalerate (OR, 0.68; 95% CIs, 0.56-0.82) and levulinate (OR, 0.60; 95% CIs, 0.46-0.79) were inversely associated with persistent tinnitus. Among metabolite classes, TAGs (normalized enrichment score [NES], 2.68), PEs (NES, 2.48), and diglycerides (NES, 1.65) were positively associated, whereas phosphatidylcholine plasmalogens (NES, −1.91), lysophosphatidylcholines (NES, −2.23), and cholesteryl esters (NES,−2.31) were inversely associated with persistent tinnitus. Conclusions and Relevance This population-based case-control study of metabolomic profiles and tinnitus identified novel plasma metabolites and metabolite classes that were significantly associated with persistent tinnitus, suggesting that metabolomic studies may help improve understanding of tinnitus pathophysiology and identify therapeutic targets for this challenging disorder." @default.
• W4327575214 created "2023-03-17" @default.
• W4327575214 creator A5002387956 @default.
• W4327575214 creator A5007242886 @default.
• W4327575214 creator A5026837154 @default.
• W4327575214 creator A5051186379 @default.
• W4327575214 creator A5057305577 @default.
• W4327575214 creator A5065121190 @default.
• W4327575214 creator A5086673943 @default.
• W4327575214 date "2023-05-01" @default.
• W4327575214 modified "2023-10-03" @default.
• W4327575214 title "Association of Plasma Metabolomic Biomarkers With Persistent Tinnitus" @default.
• W4327575214 cites W1506816544 @default.
• W4327575214 cites W1581818288 @default.
• W4327575214 cites W1703528746 @default.
• W4327575214 cites W1799202546 @default.
• W4327575214 cites W1927652301 @default.
• W4327575214 cites W1958805324 @default.
• W4327575214 cites W1965375056 @default.
• W4327575214 cites W1967190893 @default.
• W4327575214 cites W1979078517 @default.
• W4327575214 cites W1981185630 @default.
• W4327575214 cites W1986424296 @default.
• W4327575214 cites W1988218008 @default.
• W4327575214 cites W2000269494 @default.
• W4327575214 cites W2015220984 @default.
• W4327575214 cites W2033513345 @default.
• W4327575214 cites W2055787048 @default.
• W4327575214 cites W2061950854 @default.
• W4327575214 cites W2070868291 @default.
• W4327575214 cites W2087327978 @default.
• W4327575214 cites W2088104136 @default.
• W4327575214 cites W2098667036 @default.
• W4327575214 cites W2105028526 @default.
• W4327575214 cites W2109291286 @default.
• W4327575214 cites W2129004651 @default.
• W4327575214 cites W2130410032 @default.
• W4327575214 cites W2134167892 @default.
• W4327575214 cites W2152127469 @default.
• W4327575214 cites W2158187071 @default.
• W4327575214 cites W2173897454 @default.
• W4327575214 cites W2327238859 @default.
• W4327575214 cites W2327831560 @default.
• W4327575214 cites W2410364613 @default.
• W4327575214 cites W2415005901 @default.
• W4327575214 cites W2481340050 @default.
• W4327575214 cites W2561930680 @default.
• W4327575214 cites W2599048283 @default.
• W4327575214 cites W2752317246 @default.
• W4327575214 cites W2753001826 @default.
• W4327575214 cites W2763873366 @default.
• W4327575214 cites W2765418108 @default.
• W4327575214 cites W2793503965 @default.
• W4327575214 cites W2793987631 @default.
• W4327575214 cites W2904519111 @default.
• W4327575214 cites W2916286829 @default.
• W4327575214 cites W2957071669 @default.
• W4327575214 cites W3008450653 @default.
• W4327575214 cites W3011415530 @default.
• W4327575214 cites W3031826761 @default.
• W4327575214 cites W3046567479 @default.
• W4327575214 cites W3081705835 @default.
• W4327575214 cites W3085092056 @default.
• W4327575214 cites W3099862724 @default.
• W4327575214 cites W3109495248 @default.
• W4327575214 cites W3119029001 @default.
• W4327575214 cites W3124395512 @default.
• W4327575214 cites W3159281161 @default.
• W4327575214 cites W3163611147 @default.
• W4327575214 cites W3166506731 @default.
• W4327575214 cites W3174757911 @default.
• W4327575214 cites W3208698611 @default.
• W4327575214 cites W4200251235 @default.
• W4327575214 cites W4200317002 @default.
• W4327575214 cites W4214697505 @default.
• W4327575214 cites W4224295109 @default.
• W4327575214 cites W4236994390 @default.
• W4327575214 cites W4246229648 @default.
• W4327575214 cites W4247276297 @default.
• W4327575214 cites W4248190536 @default.
• W4327575214 cites W4249214711 @default.
• W4327575214 cites W4253652974 @default.
• W4327575214 doi "https://doi.org/10.1001/jamaoto.2023.0052" @default.
• W4327575214 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36928544" @default.
• W4327575214 hasPublicationYear "2023" @default.
• W4327575214 type Work @default.
• W4327575214 citedByCount "1" @default.
• W4327575214 crossrefType "journal-article" @default.
• W4327575214 hasAuthorship W4327575214A5002387956 @default.
• W4327575214 hasAuthorship W4327575214A5007242886 @default.
• W4327575214 hasAuthorship W4327575214A5026837154 @default.
• W4327575214 hasAuthorship W4327575214A5051186379 @default.
• W4327575214 hasAuthorship W4327575214A5057305577 @default.
• W4327575214 hasAuthorship W4327575214A5065121190 @default.
• W4327575214 hasAuthorship W4327575214A5086673943 @default.
• W4327575214 hasConcept C126322002 @default.
• W4327575214 hasConcept C151956035 @default.
• W4327575214 hasConcept C156957248 @default.

• next